Overview


According to FutureWise analysis the market for Asia-Pacific IVF Services in 2023 is US$ 12.9 billion, and is expected to reach US$ 46.3 billion by 2031 at a CAGR of 17.30%.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Asia-Pacific IVF Services Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Asia-Pacific IVF Services Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Apollo Hospitals Dhaka
  • Australian Concept Infertility Medical Center (ACIMC)
  • Bahosi Fertility Centre
  • Bangkok IVF center
  • Bloom Fertility and Healthcare
  • Bloom Fertility Center
  • Bourn Hall Fertility Center
  • Bumrungrad International Hospital
  • Center for Advanced Reproductive Medicine and Infertility
  • CHA Fertility Center
  • Chennai Fertility Center
  • Cloudnine Fertility
  • Damai Service Hospital
  • Fatemieh Infertility Center
  • Fertility Associates
  • Fertility Centre Nepal (Part of Wecare Health Services, India)
  • Fertility First
  • Flinders Reproductive Medicine Pty Ltd
  • Genea Oxford Fertility Limited
  • IHH Healthcare Berhad
  • IVF NAMBA Clinic

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Cycle Type

  • Fresh IVF Cycles (Non-Donor)
  • Thawed IVF Cycles (Non-Donor)
  • Donor Egg IVF Cycles

By End User

  • Fertility Clinics
  • Hospitals
  • Surgical centers
  • Clinical research institutes

By Region

  • Japan
  • China
  • India
  • Australia and New Zealand
  • ASEAN
  • Rest of Asia Pacific

  • Tier 1 players-established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Asia-Pacific IVF Services Market By Cycle Type, By End User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions—Japan, China, India, Australia and New Zealand, ASEAN, Rest of Asia Pacific.
  • To record and evaluate competitive landscape mapping-product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization services offered are free of charge with purchase of any license of the report.
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1 . Years Considered for the Study
         3.2 . Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1 . Secondary Data
          1.1.1 . Key Data from Secondary Sources
         1.2 . Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Asia-Pacific IVF Services Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Asia-Pacific IVF Services Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Asia-Pacific IVF Services Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Asia-Pacific IVF Services Market, By Cycle Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Fresh IVF Cycles (Non-Donor)
        2. Thawed IVF Cycles (Non-Donor)
        3. Donor Egg IVF Cycles

  • 8.   Asia-Pacific IVF Services Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Fertility Clinics
        2. Hospitals
        3. Surgical centers
        4. Clinical research institutes

  • 9.   Asia Pacific IVF Services Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 10.   Market Share Analysis and Competitive Landscape
    •   1. Asia Pacific Landscape - Key Players, Revenue and Presence
        2. Asia Pacific Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Asia Pacific Emerging Companies
        4. Asia Pacific - Market Share Analysis and Key Regional Players
        5. Asia Pacific Key Player - Growth Matrix
  • 11.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Apollo Hospitals Dhaka
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Australian Concept Infertility Medical Center (ACIMC)
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Bahosi Fertility Centre
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Bangkok IVF center
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Bloom Fertility and Healthcare
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Bloom Fertility Center
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Bourn Hall Fertility Center
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Bumrungrad International Hospital
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Center for Advanced Reproductive Medicine and Infertility
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. CHA Fertility Center
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Chennai Fertility Center
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Cloudnine Fertility
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. Damai Service Hospital
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. Fatemieh Infertility Center
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15. Fertility Associates
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview
        16. Fertility Centre Nepal (Part of Wecare Health Services, India)
         16.1. Company Overview
         16.2. Product Portfolio
         16.3. SWOT Analysis
         16.4. Financial Overview
         16.5. Strategic Overview
        17. Fertility First
         17.1. Company Overview
         17.2. Product Portfolio
         17.3. SWOT Analysis
         17.4. Financial Overview
         17.5. Strategic Overview
        18. Flinders Reproductive Medicine Pty Ltd
         18.1. Company Overview
         18.2. Product Portfolio
         18.3. SWOT Analysis
         18.4. Financial Overview
         18.5. Strategic Overview
        19. Genea Oxford Fertility Limited
         19.1. Company Overview
         19.2. Product Portfolio
         19.3. SWOT Analysis
         19.4. Financial Overview
         19.5. Strategic Overview
        20. IHH Healthcare Berhad
         20.1. Company Overview
         20.2. Product Portfolio
         20.3. SWOT Analysis
         20.4. Financial Overview
         20.5. Strategic Overview
        21. IVF NAMBA Clinic
         21.1. Company Overview
         21.2. Product Portfolio
         21.3. SWOT Analysis
         21.4. Financial Overview
         21.5. Strategic Overview

  • 12.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by
                  administrations
        5. The overall economic slowdown of the developing and developed nations

  • 13.   FutureWise SME Key Takeaway Points for Client

Related Market

IVF Services Market

Read More

India IVF Services Market

Read More

U.S. IVF services Market

Read More
Partner

Our Clients